SHZ · —

Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) Stock

$7.58 -5.49% SHZ: 002412.SZ —

—

Valuation

MetricValue
Price$7.58
Market Cap$4.97B
P/E Ratio21.02
P/B Ratio2.12
P/S Ratio4.94
EPS (TTM)$0.47
52-Week High$14.23
52-Week Low$5.32
Dividend Yield3.08%

Financials & Margins

MetricValue
ROE10.28%
ROA5.05%
ROCE—
Gross Margin77.77%
Operating Margin20.96%
Net Margin23.48%
Debt/Equity0.00
Current Ratio14.79

Latest News

Fitch upgrades Portugal to A+, its best credit rating in 15 years Euronews · Sep 6, 2026 Smiling face of Germany's far-right AfD: Ulrich Siegmund AFP · Sep 6, 2026 Where Will SCHD Stock Be in 5 Years? Motley Fool · Sep 6, 2026 Bart Mitchell: Zoning, Not Money, Blocks Affordable Housing CRE Daily · Sep 6, 2026 Lebanon president calls for US help as Israeli strikes kill 7 AFP · Sep 6, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio1.09
EV / EBITDA18.61
FCF Yield—
Quick Ratio10.82
Interest Coverage—
Return 1Y18.71%
Return 3Y20.33%
Return 5Y53.11%

Ownership

Insiders Held52.87%
Institutions Held0.22%
Institutions Float Held0.46%

About Hunan Hansen Pharmaceutical Co., Ltd.

—

Hunan Hansen Pharmaceutical Co., Ltd. is led by CEO Zhengqing Liu, employs 2,108 people, headquartered in Yiyang, CN, publicly traded since 2010.

Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) stock trades at $7.58 with a market capitalization of $4.97B. The stock is valued at a price-to-earnings (P/E) ratio of 21.02, price-to-book of 2.12, price-to-sales of 4.94. Over the past 52 weeks the stock has ranged between $5.32 and $14.23, and currently trades 46.7% below its 52-week high. It pays a dividend yielding 3.08%.

On profitability, Hunan Hansen Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 10.28%, an operating margin of 20.96%, a net profit margin of 23.48%.

Official website: www.hansenzy.com

Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) — frequently asked questions

What is Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) stock price today?

Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) is currently trading at $7.58, down 5.49% today.

What is 002412.SZ P/E ratio?

Hunan Hansen Pharmaceutical Co., Ltd.'s P/E ratio is 21.02. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is 002412.SZ return on equity (ROE)?

Hunan Hansen Pharmaceutical Co., Ltd.'s return on equity (ROE) is 10.28%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Hunan Hansen Pharmaceutical Co., Ltd.'s market cap?

Hunan Hansen Pharmaceutical Co., Ltd. has a market capitalization of $4.97B.

Does 002412.SZ pay a dividend?

Yes. Hunan Hansen Pharmaceutical Co., Ltd. currently yields 3.08%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does 002412.SZ carry?

Hunan Hansen Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.00. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 002412.SZ's profit margin?

Hunan Hansen Pharmaceutical Co., Ltd. reports a net profit margin of 23.48% — the share of revenue left after every cost, including tax and interest.

What sector is 002412.SZ in?

Hunan Hansen Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 002412.SZ listed on?

Hunan Hansen Pharmaceutical Co., Ltd. trades on SHZ under the ticker 002412.SZ.

What is 002412.SZ's 52-week range?

Over the last year Hunan Hansen Pharmaceutical Co., Ltd. has traded between $5.32 and $14.23.

Related — Stocks

USDE StablecoinX Inc. $1.00 -0.01% BVC BitVentures Limited - Ordinary Share $14.00 -0.36% PURR Hyperliquid Strategies Inc $9.07 +3.30% HBNB Hotel101 Global Holdings Corp. $4.42 -8.45% BLSM BlossomHill Therapeutics, Inc. $16.39 +12.03% FCBM First Carolina Financial Services, Inc. $12.93 -0.08% BRBI BRBI BR Partners S.A. - ADSs $9.84 -34.63% QMLS QumulusAI, Inc. $3.14 -1.87% HCHL Happy City Holdings Limited $3.96 +0.00% XLAB Exascale Labs Holdings Inc. $3.39 +1.19% QTEX QTREX Quantum Ltd. $1.29 -7.19% VIDA VIDA Global Inc. $1.01 -4.48%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens 002412.SZ currently matches

On the figures above, Hunan Hansen Pharmaceutical Co., Ltd. passes the filters for 19 of our ready-made screens, among them Dividend Stocks, Dividend Stocks Under $10, Low Debt Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Dividend StocksDividend Stocks Under $10Low Debt Dividend StocksLow Debt StocksHigh Profit Margin StocksDay Losers StocksStocks Under $10Debt Free Stocks Under $100Debt Free StocksHigh Margin Dividend StocksStocks Under $100Stocks Under $50High Gross Margin StocksDividend Yield Over 3%Mid Cap StocksStocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 StocksHigh Current Ratio Stocks

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.